Plant-derived extracellular vesicles as a novel tumor-targeting delivery system for cancer treatment
Frontiers in Cell and Developmental Biology · 24.06.2025 · 13
DOI: 10.3389/fcell.2025.1589550 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 24.06.2025. Verfasst von Hanjin Wu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Shaoxing People's Hospital, Shaoxing, Zhejiang, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Extracellular vesicles (EVs) are vital mediators of intercellular communication, helping to transfer bioactive molecules to target cells and demonstrating significant potential in antitumor therapy. Currently, EVs are primarily utilized in clinical applications such as biomarker discovery, cell-free therapeutic agents, drug delivery systems, pharmacokinetic studies, and cancer vaccines. Plant-derived EVs (P-EVs) contain a range of lipids, proteins, nucleic acids, and other metabolite cargos, and it is possible to extract them from various plant tissues, including juice, flesh, and roots. These vesicles perform multiple biological functions, including modulating cellular restructuring, enhancing plant immunity, and defending against pathogens. P-EVs have also been investigated in various clinical trials due to their promising therapeutic properties. In the context of precision medicine, selectively inhibiting solid tumor growth while preserving the viability of normal human cells remains a primary objective of cancer therapy. However, the tumor microenvironment (TME) supports tumor progression through the facilitation of immune evasion, supplying nutrients, and promoting invasive growth, metastatic processes, and treatment resistance. Consequently, the development of novel antitumor agents is essential. Owing to their inherent therapeutic properties and potential as treatment vectors, natural P-EVs represent a promising biocompatible platform for targeted solid tumor therapy. These vesicles may contribute to remodeling the TME and enhancing antitumor immunity, offering innovative avenues for cancer treatment and improved human health.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
- Department of Cadre Healthcare, Shaoxing People's Hospital, Shaoxing, Zhejiang, China.
- Department of Burn and Plastic Surgery-Hand Surgery, Changshu Hospital Affiliated to Soochow University, Changshu No. 1 People's Hospital, Changshu, Jiangsu, China.
Zitieren
APA
Wu, H., Shi, M., Meng, L., Qiu, J., Jiang, Y., Qian, D., & Shen, F. (2025). Plant-derived extracellular vesicles as a novel tumor-targeting delivery system for cancer treatment. Frontiers in Cell and Developmental Biology, 13. https://doi.org/10.3389/fcell.2025.1589550
Vancouver
Wu H, Shi M, Meng L, Qiu J, Jiang Y, Qian D, et al. Plant-derived extracellular vesicles as a novel tumor-targeting delivery system for cancer treatment. Frontiers in Cell and Developmental Biology. 2025;13. doi:10.3389/fcell.2025.1589550
BibTeX
@article{Wu2025,
author = {Wu, Hanjin and Shi, Mengya and Meng, Liwei and Qiu, Jie and Jiang, Yuancong and Qian, Da and Shen, Fengqing},
title = {Plant-derived extracellular vesicles as a novel tumor-targeting delivery system for cancer treatment},
journal = {Frontiers in Cell and Developmental Biology},
year = {2025},
volume = {13},
doi = {10.3389/fcell.2025.1589550}
}
EUVIMED